Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-08-01
2006-08-01
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S328000, C530S350000
Reexamination Certificate
active
07083790
ABSTRACT:
The present invention provides a DNA encoding a novel extracellular serine protease termed Tumor Antigen Derived Gene-14 (TADG-14) which is overexpressed in ovarian, breast and colon carcinoma samples. Also provided are vector and host cells capable of expressing the DNA of the present invention, as well as the uses of the DNA and protein of the present invention.
REFERENCES:
patent: 6080409 (2000-06-01), Laus et al.
patent: 6100059 (2000-08-01), Southan et al.
patent: 6203979 (2001-03-01), Bandman et al.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Kuby et al., 1994, Immunology, second edition, pp. 85-96.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 491-495.
O'Brien Timothy J.
Underwood Lowell J.
Adler Benjamin Aaron
Chan Christina
Huynh Phuong N
The Board of Trustees of the University of Arkansas Systems
LandOfFree
Extracellular serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracellular serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracellular serine protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3627438